Our News on Newswise

Newswise: 62e15dc64a410_microgliacells-istock.jpg

Beyond the blood-brain barrier: HIV research at Texas Biomed gets NIH funding boost

Texas Biomed has received a $3.9 million NIH grant to explore how gene-editing technology may help eradicate HIV in the brain.
27-Jul-2022 12:10 PM EDT Add to Favorites

Newswise: 62d96700476c8_luis-martinez-sobrido.jpg

Texas Biomed working to accelerate COVID-19 drug development

Researchers at Texas Biomed have received approval to work with a weakened, non-harmful version of SARS-CoV-2 in biosafety level 2 (BSL-2) laboratories, which makes it safer, faster and easier to study the virus, its mutations, and to identify new...
21-Jul-2022 10:55 AM EDT Add to Favorites

Newswise: 62d1be9d5d082_LuisMartinezSobrido.jpeg

Texas Biomed tapped for national ‘Dream Team’ developing antivirals against COVID-19 and other threats

Texas Biomedical Research Institute Professor Luis Martinez-Sobrido, PhD, an expert in virology, vaccines and antiviral research, has been recruited to collaborate with three of the nine Antiviral Drug Discovery (AViDD) Centers for Pathogens of...
15-Jul-2022 3:50 PM EDT Add to Favorites

Newswise: 6273e7eaddf24_mtdanalysis.png

New Tool Integrates Microbiome and Host Genetic Sequencing Analysis

A new software tool makes it easier to study relationships between a host, its microbiome and pathogens like HIV or SARS-CoV-2.
5-May-2022 11:05 AM EDT Add to Favorites

Newswise: 623b5403dd4d5_JoanneTurner2.jpg

Texas Biomed selected as premier NIH training center for TB researchers

The $5.8 million center at Texas Biomed is one of the inaugural Interdisciplinary NexGen TB Research Advancement Centers (IN-TRAC) funded by the U.S. National Institute of Allergy and Infectious Diseases.
23-Mar-2022 1:35 PM EDT Add to Favorites

Newswise: 6234d748164af_sarscov2spikesections.png

Texas Biomed and partners discover new, potent COVID-19 antibody cocktail

Researchers at Texas Biomed and University of Alabama at Birmingham discovered an antibody cocktail against COVID-19 that appears effective against all variants and other coronaviruses. The cocktail has been exclusively licensed to Aridis...
18-Mar-2022 3:20 PM EDT Add to Favorites

Newswise: 622bb6adea437_Joanne Turner 2.jpg

How to make the TB vaccine more effective

Briefly blocking a key molecule when administering the only approved vaccine for tuberculosis vastly improves long-term protection against the devastating disease in mice, researchers from Texas Biomedical Research Institute report this week in the...
11-Mar-2022 4:00 PM EST Add to Favorites

Newswise: 620c129cd7eb0_2weekvs4week.png

Starting antiretroviral therapy early essential to battling not one, but two killers

Medication against the nonhuman primate version of HIV given two weeks after infection helped keep tuberculosis in check.
15-Feb-2022 4:05 PM EST Add to Favorites

See All News

Our Experts on Newswise

Newswise: JoanneTurner.jpg

Researcher on TB and the Intersection of Aging and Immune Function Joins Texas Biomed as Vice President for Research

Joanne Turner, Ph.D., a preeminent scientist in tuberculosis (TB) research, has joined the Texas Biomed team, bringing with her a portfolio of research on the immune system in relation to Mycobacterium tuberculosis infection and aging.
19-Oct-2017 1:05 PM EDT

See All Experts

Our YouTube Videos

Youtube feed not yet configured. Is this your Newswise member page? Contact member@newswise.com to configure this module.


Since its founding in 1941 by Thomas B. Slick Jr., the Texas Biomedical Research Institute has gained worldwide recognition in scientific and academic communities for the quality of its basic research. Each year, our scientists publish well over 100 articles in the international scientific literature. Their discoveries contribute important new information that helps advance the scientific community's effort to improve health and save lives.



Lisa Cruz
Vice President, Communications



Nicole Foy
PR Director



Ja'Nise Solitaire
Media and Communicatons Specialist